Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for ... Read More
Lupin expands US women’s health portfolio with $150m acquisition of Symbiomix Therapeutics
Lupin Limited, a Mumbai-based generics pharmaceutical company, has strategically broadened its foothold in the women’s health sector by acquiring Symbiomix Therapeutics. The acquisition, valued at ... Read More